BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• BioForest

  Lumen Bioscience Expands Biologics Manufacturing Capacity with Lease of Historic Seattle Bakery

  Lumen Bioscience, a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases, announced the future expansion of its biologics manufacturing capabilities through a lease agreement to occupy a former bakery in the Fremont-Wallingford neighborhood of Seattle.

  July 15, 2021

   · 

  2 min read
• Business

  Moderna to Report Second Quarter Financial Results on Thursday, August 5, 2021

  Moderna, Inc. today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, August 5, 2021 to report its second quarter 2021 financial results, and provide a corporate update.

  July 15, 2021

   · 

  2 min read
• LENSAR Announces In-Person Demonstrations of Its Next Generation ALLY™ System and Multiple Data Presentations at the American Society of Cataract and Refractive Surgery (ASCRS) 2021 Annual Meeting

  LENSAR, Inc. today announced a total of 12 abstracts highlighting LENSAR’s technology have been accepted for presentation at the 2021 Annual Meeting of the American Society of Cataract and Refractive Surgery.

  July 15, 2021

   · 

  7 min read
• Nexus TKO Anti-Reflux Needleless Connector Produces the Least Amount of Blood Reflux, New Study Confirms

  - Uncontrolled blood reflux leads to serious patient safety issues like thrombotic occlusions and infection - Only needleless connectors with bidirectional flow control - like Nexus TKO - can automatically prevent blood reflux, consistent with the 2021 INS Standards

  July 15, 2021

   · 

  4 min read
• Business

  GentiBio and Forge Biologics Announce Viral Vector Contract Development and GMP Manufacturing Partnership

  GentiBio, Inc. announced a strategic development and manufacturing partnership today to advance GentiBio’s unique immune tolerance platform.

  July 15, 2021

   · 

  4 min read
• Business

  ImmunoPrecise to Report Financial Results and Business Highlights for Fiscal Year 2021

  IMMUNOPRECISE ANTIBODIES LTD. today announced the Company will host a conference call to discuss its financial results and business highlights for the full fiscal year 2021.

  July 15, 2021

   · 

  2 min read
• Business

  ViewRay Announces Conference Call for Second Quarter 2021 Financial Results to be Held After Market on August 5, 2021

  ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its second quarter 2021 financial results.

  July 15, 2021

   · 

  3 min read
• Business

  NCCN Announces Selected Projects to Study Neratinib in Collaboration with Puma Biotechnology, Inc.

  The National Comprehensive Cancer Network ® ( NCCN ® ) Oncology Research Program ( ORP ) today announced three research projects that have been selected for funding to evaluate neratinib in various tumor types.

  July 15, 2021

   · 

  3 min read
• Pharm Country

  Oligomerix Appoints Chief Medical Officer William Erhardt, M.D., to Board of Directors

  Oligomerix, Inc. today announced the appointment of William Erhardt, M.D., Chief Medical Officer of Oligomerix, to its Board of Directors.

  July 15, 2021

   · 

  3 min read
• Business

  NeuroMetrix, Inc. Announces Date for Second Quarter 2021 Financial Results Conference Call

  NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2021 second quarter financial results before the opening of the market on July 22, 2021.

  July 15, 2021

   · 

  1 min read